Devices › Oxygenator, cardiopulmonary bypass
Device brand name · Oxygenator cardiopulmonary bypass
Capiox FX Advance Hollow Fiber Oxygenator w Integrated AF w Hardshell Res.: medical device reports filed with FDA
160 reports name it, 2023–2026. Manufacturer given most often on reports: Terumo Cardiovascular Systems. Product code DTZ.
- 160
- device reports naming the brand
- 0% of all MAUDE reports · about 58 a year
- 68
- reports, 12 months to August 2026
- 48 in the 12 months before
- 89.4%
- classified as malfunction
- 78.2% across the product code
- 6.3%
- classified as death, as reported
- 10 reports · not verified by FDA
160 medical device reports received by FDA name the brand "Capiox FX Advance Hollow Fiber Oxygenator w Integrated AF w Hardshell Res." (oxygenator cardiopulmonary bypass); the manufacturer given most often on reports is Terumo Cardiovascular Systems; received from October 2023 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
68 reports arrived in the 12 months to August 2026, up 42% from 48 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (89.4%), death (6.3%) and injury (4.4%); across all oxygenator, cardiopulmonary bypass reports (product code DTZ) death is recorded in 4.2% and malfunction in 78.2%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are leak/splash (18.8%), air/gas in device (8.8%) and break (3.8%). The patient problems coded most often are hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 10,703 reports carrying product code DTZ. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Leak/splashthe device leaked | 30 | 18.8% | 16.8% |
| Air/gas in device | 14 | 8.8% | 1.4% |
| Breakthe device broke | 6 | 3.8% | 3.3% |
| Device damaged prior to receipt by user | 6 | 3.8% | 0.4% |
| Decrease in pressure | 5 | 3.1% | 0.8% |
| Defective component | 5 | 3.1% | 0.8% |
| Increase in pressure | 5 | 3.1% | 7% |
| Obstruction of flow | 4 | 2.5% | 2.4% |
| Defective devicethe device was defective | 3 | 1.9% | 0.2% |
| Infusion or flow problema problem with flow or infusion | 3 | 1.9% | 2.5% |
| Loss of or failure to bond | 3 | 1.9% | 0.1% |
| Particulates | 3 | 1.9% | 0.2% |
| Pressure problem | 3 | 1.9% | 2.8% |
| Coagulation in device or device ingredient | 2 | 1.3% | 1.2% |
| Crackthe device cracked | 2 | 1.3% | 2.6% |
| Gas/air leak | 2 | 1.3% | 0.5% |
| Improper flow or infusion | 2 | 1.3% | 0.7% |
| Incorrect, inadequate or imprecise result or readings | 2 | 1.3% | 0.1% |
| Insufficient flow or under infusion | 2 | 1.3% | 0.6% |
| Low readingsreadings were too low | 2 | 1.3% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hemorrhage/blood loss/bleeding | 10 | 6.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Capiox FX Advance Hollow Fiber Oxygenator w Integrated AF w Hardshell Res. | Product code DTZ | All MAUDE reports |
|---|---|---|---|
| Reports | 160 | 10,703 | 26,136,888 |
| Share of that pool | — | 1.5% | 0% |
| Classified as death, per 1,000 reports | 63 | 42 | 9 |
| Classified as injury | 4.4% | 14.5% | 36.2% |
| Classified as malfunction | 89.4% | 78.2% | 62.3% |
| Filed by the manufacturer | 100% | 93.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DTZ
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Fusion Hollow Fiber Oxygenator | 1,515 | 996 | 0.7% |
| Capiox Fx Oxygenator | 409 | 0 | 1.5% |
| Tubing Set | 336 | 104 | 14% |
| Sterile Fx25rwc W/ Res | 279 | 0 | 2.5% |
| Sterile Fx25rec W/Res | 277 | 0 | 1.4% |
| Affinity Nt Balance | 271 | 150 | 0.4% |
| Oxygenator Cardiopulmonary Bypass | 274 | 0 | 4.7% |
| Hls Set Advanced | 215 | 0 | 12.1% |
| Hlm Tubing Set W/Bioline Coating | 439 | 0 | 7.1% |
| Navilyst Medical | 252 | 0 | 0.4% |
| Cardiovascular Procedure Kit | 553 | 0 | 1.3% |
| Shunt Sensor Sys500 | 712 | 0 | 0.1% |
| AngioDynamics | 174 | 14 | 1.7% |
| Heart Lung Machine | 1,873 | 283 | 3.7% |
| Apex | 876 | 78 | 1.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Capiox FX Advance Hollow Fiber Oxygenator w Integrated AF w Hardshell Res. reports
How many FDA reports name Capiox FX Advance Hollow Fiber Oxygenator w Integrated AF w Hardshell Res.?
160 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 68 in the latest 12 months.
What kinds of events are reported?
malfunction (89.4%), death (6.3%) and injury (4.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
leak/splash (18.8%), air/gas in device (8.8%), break (3.8%), device damaged prior to receipt by user (3.8%) and decrease in pressure (3.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Capiox FX Advance Hollow Fiber Oxygenator w Integrated AF w Hardshell Res. was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.